Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-lipoic Acid in Schizophrenic Subjects Stabilized With Atypical Antipsychotics
NCT06787781Completed
- Sponsor
- University of Messina
- Start
- Jun 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of alpha-lipoic acid in schizophrenia, sponsored by University of Messina. Primary endpoint: Blood Parameters: Lipid and Carbohydrate Framework at 12 weeks. Started Jun 2021; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT06787781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06787781.